Nu Skin (NUS) stock at 52-week High & further regional approvals in China!

Nu Skin (NUS) stock was at a 52-week high
last Friday...below explains why!

Nu Skin Enterprises "buy," target price raised

2:23a.m. - Wedbush Morgan Securities
NEW YORK, March 16 (newratings.com) -
Analysts at Wedbush Morganreiterate their "buy"
rating on Nu Skin Enterprises (NUS), while raising
their estimates for the company. The target price
has been raised from $19 to $22.

In a research note dated March 13 and published
on March 14, the analysts mention that given that
only 14% of the company's sales are from the US,
Nu Skin Enterprises appears well positioned to
benefit going forward from the sharp weakening
of the US dollar. Nu Skin Enterprises is likely to
continue to get further regional approvals in China
over the forthcoming several months, the analysts say.
The sales of nutritional supplements and personal care
products are generallyrecession-resistant, and, hence,
the demand for the company's core product lines
would continue to be intact, despite the sluggishness
in macroeconomic conditions, Wedbush Morgan adds.
The EPS estimates for 2008 has been raised
from $1.19 to $1.23.